EP1993606A4 - Immunoglobulines de plasma de vitiligo pour le traitement du mélanome - Google Patents

Immunoglobulines de plasma de vitiligo pour le traitement du mélanome

Info

Publication number
EP1993606A4
EP1993606A4 EP07794323A EP07794323A EP1993606A4 EP 1993606 A4 EP1993606 A4 EP 1993606A4 EP 07794323 A EP07794323 A EP 07794323A EP 07794323 A EP07794323 A EP 07794323A EP 1993606 A4 EP1993606 A4 EP 1993606A4
Authority
EP
European Patent Office
Prior art keywords
vitiligo
immunoglobulins
plasma
melanoma therapy
melanoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07794323A
Other languages
German (de)
English (en)
Other versions
EP1993606A2 (fr
Inventor
Yehuda Shoenfeld
Pnina Fishman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GAMMACAN Ltd
Original Assignee
GAMMACAN Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GAMMACAN Ltd filed Critical GAMMACAN Ltd
Publication of EP1993606A2 publication Critical patent/EP1993606A2/fr
Publication of EP1993606A4 publication Critical patent/EP1993606A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP07794323A 2006-02-15 2007-02-15 Immunoglobulines de plasma de vitiligo pour le traitement du mélanome Withdrawn EP1993606A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77331906P 2006-02-15 2006-02-15
PCT/US2007/003918 WO2007117356A2 (fr) 2006-02-15 2007-02-15 Immunoglobulines de plasma de vitiligo pour le traitement du melanome

Publications (2)

Publication Number Publication Date
EP1993606A2 EP1993606A2 (fr) 2008-11-26
EP1993606A4 true EP1993606A4 (fr) 2010-01-20

Family

ID=38581540

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07794323A Withdrawn EP1993606A4 (fr) 2006-02-15 2007-02-15 Immunoglobulines de plasma de vitiligo pour le traitement du mélanome

Country Status (4)

Country Link
EP (1) EP1993606A4 (fr)
AU (1) AU2007237163A1 (fr)
CA (1) CA2642632A1 (fr)
WO (1) WO2007117356A2 (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997045744A1 (fr) * 1996-05-28 1997-12-04 University Of British Columbia Anticorps specifiques du melanome et du cancer de la prostate pour immunodetection et immunotherapie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994269A (en) * 1989-03-17 1991-02-19 Miles Inc. Topical use of antibodies for prevention or treatment of pseudomonas infections
US6290991B1 (en) * 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US6685940B2 (en) * 1995-07-27 2004-02-03 Genentech, Inc. Protein formulation
PL1750683T3 (pl) * 2004-04-23 2013-05-31 Amgen Inc Formuły o przedłużonym uwalnianiu

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997045744A1 (fr) * 1996-05-28 1997-12-04 University Of British Columbia Anticorps specifiques du melanome et du cancer de la prostate pour immunodetection et immunotherapie

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BAR-DAYAN Y ET AL: "ANTIBODIES TO THE CYTOPLASM, CELL MEMBRANE AND NUCLEAR MEMBRANE OF MALIGNANT NEOPLASMS IN POOLED NORMAL HUMAN POLYSPECIFIC IMMUNOGLOBULIN G", INTERNATIONAL JOURNAL OF ONCOLOGY, DEMETRIOS A. SPANDIDOS ED. & PUB, GR, vol. 15, no. 6, 1 December 1999 (1999-12-01), pages 1091 - 1096, XP009011084, ISSN: 1019-6439 *
FISHMAN P ET AL: "AUTOIMMUNITY AND CANCER - BENEFICIAL RELATIONSHIPS: A NEW CONCEPT FOR THE PRODUCTION OF HUMAN MONOCLONAL ANTIBODIES (REVIEW)", INTERNATIONAL JOURNAL OF ONCOLOGY, DEMETRIOS A. SPANDIDOS ED. & PUB, GR, vol. 10, no. 5, 1 May 1997 (1997-05-01), pages 901 - 904, XP000867200, ISSN: 1019-6439 *
FISHMAN P ET AL: "Vitiligo autoantibodies are effective against melanoma.", CANCER 15 OCT 1993, vol. 72, no. 8, 15 October 1993 (1993-10-15), pages 2365 - 2369, XP002559449, ISSN: 0008-543X *
KUHN A ET AL: "1st International Conference on Cutaneous Lupus Erythematosus Dusseldorf, Germany, September 1-5, 2004", AUTOIMMUNITY REVIEWS, ELSEVIER, AMSTERDAM, NL, vol. 4, no. 1, 1 January 2005 (2005-01-01), pages 66 - 78, XP004713811, ISSN: 1568-9972 *
SHOENFELD Y ET AL: "Shrinkage of melanoma metastases following high dose intravenous immunoglobulin treatment.", THE ISRAEL MEDICAL ASSOCIATION JOURNAL : IMAJ SEP 2001, vol. 3, no. 9, September 2001 (2001-09-01), pages 698 - 699, XP002559450, ISSN: 1565-1088 *

Also Published As

Publication number Publication date
WO2007117356A3 (fr) 2008-01-31
EP1993606A2 (fr) 2008-11-26
CA2642632A1 (fr) 2007-10-18
WO2007117356A2 (fr) 2007-10-18
AU2007237163A1 (en) 2007-10-18

Similar Documents

Publication Publication Date Title
EP2069047A4 (fr) Réacteur à plasma
GB0712494D0 (en) Substrate reduction therapy
EP2123136A4 (fr) Source plasma améliorée
HK1142844A1 (en) Showerhead
GB0610680D0 (en) Therapeutic compounds
GB0603041D0 (en) Therapeutic compounds
IL197389A0 (en) Prophylactic or therapeutic agent for cancer
GB2461816B (en) Plasma treatment apparatus
EP2035369A4 (fr) Composés thérapeutiques
GB0606663D0 (en) Therapeutic compounds
HUE038611T2 (hu) Vitiligo terápia
GB0615809D0 (en) Therapeutic compounds
GB0612971D0 (en) Therapeutic compounds
EP2018873A4 (fr) Agent prophylactique/therapeutique pour le cancer
EP2079704A4 (fr) Composés thérapeutiques
GB2467671B (en) Plasma deposition apparatus
GB0605573D0 (en) Therapeutic Compounds
GB0603455D0 (en) Therapeutic compounds
EP1993606A4 (fr) Immunoglobulines de plasma de vitiligo pour le traitement du mélanome
GB0608269D0 (en) Therapeutic compounds
GB2441499B (en) Slimming Spray
GB0613584D0 (en) Therapeutic compounds
HU0700326D0 (en) Plasma throner
AU2007900499A0 (en) Therapy for vitiligo
IL178522A (en) Integrated plasma source

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080915

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 39/395 20060101ALI20091210BHEP

Ipc: A61K 35/16 20060101ALI20091210BHEP

Ipc: C07K 16/06 20060101AFI20091210BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20091218

17Q First examination report despatched

Effective date: 20100409

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100820